MUSCULAR DYSTROPHIES
Clinical trials for MUSCULAR DYSTROPHIES explained in plain language.
Never miss a new study
Get alerted when new MUSCULAR DYSTROPHIES trials appear
Sign up with your email to follow new studies for MUSCULAR DYSTROPHIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for duchenne: targeted drug trial aims to slow muscle decline
Disease control Not yet recruitingThis study tests an experimental drug called AOC 1044 (delpacibart zotadirsen) in 70 boys aged 7 to 16 with Duchenne muscular dystrophy who have a specific genetic change (exon 44 skipping). The drug is given through a vein and aims to improve muscle function, such as how fast th…
Matched conditions: MUSCULAR DYSTROPHIES
Phase: PHASE3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Virtual park cycling aims to slow muscle decline in kids
Symptom relief Not yet recruitingThis study tests whether children with muscle diseases (like muscular dystrophy) who cycle while using a virtual park app can slow down their loss of movement skills. About 22 kids aged 6 to 17 will first get standard therapy for 3 months, then add the virtual park cycling 3 time…
Matched conditions: MUSCULAR DYSTROPHIES
Phase: NA • Sponsor: Istituto di Sistemi e Tecnologie Industriali Intelligenti per il Manifatturiero Avanzato • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC